Metabolic Response to Folate Supplementation in Overweight Women with Polycystic Ovary Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial (vol 58, pg 1465, 2014) (Expression of Concern of Vol 58, Pg 1465, 2014)

被引：1

作者：

Asemi, Zatollah

Karamali, Maryam

Esmaillzadeh, Ahmad

机构：

来源：

MOLECULAR NUTRITION & FOOD RESEARCH | 2023年 / 67卷 / 17期

关键词：

D O I：

10.1002/mnfr.202370300

中图分类号：

TS2 [食品工业];

学科分类号：

0832 ;

摘要：

引用

页数：1

共 50 条

[1] Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial
Asemi, Zatollah
Karamali, Maryam
Esmaillzadeh, Ahmad
MOLECULAR NUTRITION & FOOD RESEARCH, 2014, 58 (07) : 1465 - 1473
[2] Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial
Samimi, M.
Asemi, Z.
Karamali, M.
Foroozanfard, F.
Esmaillzadeh, A.
HUMAN REPRODUCTION, 2014, 29 : 5 - 6
[3] The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial (Expression of Concern of Vol 81, Pg 582, 2014)
不详
CLINICAL ENDOCRINOLOGY, 2023, 98 (05) : 747 - 747
[4] Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial (Expression of Concern of Vol 67, Pg 42, 2015)
不详
ANNALS OF NUTRITION AND METABOLISM, 2023,
[5] Metabolic response to selenium supplementation in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
Jamilian, M.
CLINICAL ENDOCRINOLOGY, 2024, 100 (06) : 593 - 593
[6] Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
Jamilian, Mehri
Razavi, Maryamalsadat
Kashan, Zohreh Fakhrie
Ghandi, Yasser
Bagherian, Tayebeh
Asemi, Zatollah
CLINICAL ENDOCRINOLOGY, 2015, 82 (06) : 885 - 891
[7] Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial (Expression of Concern of Vol 84, Pg 851, 2015)
不详
CLINICAL ENDOCRINOLOGY, 2023, 98 (05) : 745 - 745
[8] Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial (Publication with Expression of Concern)
Jamilian, Mehri
Foroozanfard, Fatemeh
Bahmani, Fereshteh
Talaee, Rezvan
Monavari, Mahshid
Asemi, Zatollah
BIOLOGICAL TRACE ELEMENT RESEARCH, 2016, 170 (02) : 271 - 278
[9] Metabolic and hormonal effects of melatonin and/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
Mohammad Alizadeh
Majid Karandish
Mohammad Asghari Jafarabadi
Lida Heidari
Roshan Nikbakht
Hossein Babaahmadi Rezaei
Reihaneh Mousavi
Nutrition & Metabolism, 18
[10] Metabolic and hormonal effects of melatonin and/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
Alizadeh, Mohammad
Karandish, Majid
Asghari Jafarabadi, Mohammad
Heidari, Lida
Nikbakht, Roshan
Babaahmadi Rezaei, Hossein
Mousavi, Reihaneh
NUTRITION & METABOLISM, 2021, 18 (01)

← 1 2 3 4 5 →